酮咯酸氨丁三醇复合瑞芬太尼在局麻腰椎孔镜术中应用.doc

酮咯酸氨丁三醇复合瑞芬太尼在局麻腰椎孔镜术中应用.doc

  1. 1、本文档共8页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
酮咯酸氨丁三醇复合瑞芬太尼在局麻腰椎孔镜术中应用

酮咯酸氨丁三醇复合瑞芬太尼在局麻腰椎孔镜术中应用   [摘要]目的 观察酮咯酸氨丁三醇复合瑞芬太尼在局麻腰椎孔镜髓核摘除术中的镇痛效果,以及对瑞芬太尼的节俭作用。方法 选择本院2014年1月~2015年12月行腰椎孔镜髓核摘除术患者50例,采用随机数字表法将患者分为两组,每组25例:瑞芬太尼辅助局麻组(R组)及酮咯酸氨丁三醇复合瑞芬太尼辅助局麻组(TR组),两组均于术前20 min给药,R组静脉注射5 ml生理盐水,TR组静脉注射30 mg酮咯酸氨丁三醇。局麻前均静脉注射0.25 μg/kg瑞芬太尼负荷量后,以0.1 μg/(kgmin)的速率输注,期间调整输注速率。术前由术者进行1%利多卡因局部浸润麻醉。术中观察并记录两组患者血压、心率的变化及瑞芬太尼用量,并记录患者低血压、心动过缓、呼吸抑制、恶心呕吐的发生情况。结果 T2~T5各时段,TR组的MAP、HR均较R组更低(P0.05)。TR组的瑞芬太尼用量减少,恶心呕吐、呼吸抑制发生率降低(P0.05)。结论 酮咯酸氨丁三醇复合瑞芬太尼用于局麻下腰椎孔镜手术可取得较好的镇痛效果,并可有效减少瑞芬太尼使用量,减少术中不良反应的发生 [关键词]酮咯酸氨丁三醇;瑞芬太尼;腰椎孔镜 [中图分类号] R614.3 [文?I标识码] A [文章编号] 1674-4721(2017)02(b)-0115-03 [Abstract]Objective To observe the analgesic effect of Ketorolac Tromethamine combined with Remifentanil in lumbar endoscopic surgery under local anesthesia,and its frugal role for Remifentanil.Methods Fifty patients received lumbar endoscopic surgery from January 2014 to December 2015 were selected and they were randomly divided into group R(n=25) (Remifentanil assisted by local anesthesia) and group TR (n=25) (Ketorolac Tromethamine combined with Remifentanil assisted by local anesthesia).Group R was intravenous injected normal saline 5 ml while group TR was intravenous injected Ketorolac Tromethamine 30 mg,they all were given drugs before 20 minutes surgery.Before local anesthesia,Remifentanil were given in the two groups initial dosage of 0.25 μg/kg and then continuous infused in dosage of 0.1μg/(kgmin),and adjusting the infusion speed.1% lidocaine local anesthesis was given by operator before surgery.During surgery,BP and HR were recorded and the usage amount of Remifentanil was calculated,and the occurrence of low blood pressure,bradyarrhythmia,respiratory depression and nausea vomiting were recorded.Results MAP and HR of group TR were lower compared to group R in the period of T2-T5 (P0.05).In group TR,the consumption of Remifentanil was less,and the occurrence rate of respiratory depression and nausea vomiting was also reduced (P0.05).Conclusion Ketorolac tromethamine combined w

文档评论(0)

docman126 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档